Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Cogdill AP"'
Autor:
Zhou Y; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Medik YB; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel B; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Zamler DB; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Chen S; Ministry of Education Key Lab of Bioinformatics and Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing, China., Chapman T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Schneider S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX., Park EM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Babcock RL; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Chrisikos TT; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Kahn LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Dyevoich AM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Pineda JE; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Wong MC; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX., Mishra AK; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX., Cass SH; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Cogdill AP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Johnson DH; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Johnson SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wadud Khan MA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Peterson CB; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Joon AY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Peng W; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Li HS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tang X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Raso MG; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Zhang X; Ministry of Education Key Lab of Bioinformatics and Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing, China., Foo WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tetzlaff MT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Diehl GE; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Clise-Dwyer K; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX., Whitley EM; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX., Gubin MM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Hwu P; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2023 Feb 06; Vol. 220 (2). Date of Electronic Publication: 2022 Nov 11.
Autor:
Vellano CP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Chelvanambi M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Witt RG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daniele JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Conforti F; Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lastrapes MJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ologun G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Guthrie Courtland Medical Center, Courtland, NY, USA., Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Immunai, New York, NY, USA., Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Prieto P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, University of Rochester, Rochester, NY, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Helmink B; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Washington University in St Louis, St Louis, MO, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kovacs JJ; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moffitt Cancer Center, Tampa, FL, USA., Peoples M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cooper ZA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; AstraZeneca, Gaithersburg, MD, USA., Zhu H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao G; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Banerjee H; Clinical Development and Analytics, Novartis Pharmaceuticals, East Hanover, NJ, USA., Lau M; Novartis Pharma, Basel, Switzerland., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pala L; Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy., Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., Segura RL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu Q; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Borthwick MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lau E; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Yates MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, University of California, San Francisco, CA, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahendra M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma X; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Logothetis C; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kulstad Z; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Feng N; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Federico L; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arur S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moran AE; Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heffernan TP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TPHeffernan@mdanderson.org., Marszalek JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
Publikováno v:
Nature [Nature] 2023 Jan; Vol. 613 (7945), pp. E3.
Autor:
Vellano CP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Chelvanambi M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Witt RG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daniele JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Conforti F; Division of Melanoma, Sarcomas, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lastrapes MJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ologun G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Guthrie Courtland Medical Center, Courtland, NY, USA., Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Immunai, New York, NY, USA., Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Prieto P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, University of Rochester, Rochester, NY, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Helmink B; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Washington University in St Louis, St Louis, MO, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kovacs JJ; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moffitt Cancer Center, Tampa, FL, USA., Peoples M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cooper ZA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; AstraZeneca, Gaithersburg, MD, USA., Zhu H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao G; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Banerjee H; Clinical Development and Analytics, Novartis Pharmaceuticals, East Hanover, NJ, USA., Lau M; Novartis Pharma, Basel, Switzerland., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pala L; Division of Melanoma, Sarcomas, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy., Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., Segura RL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu Q; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Borthwick MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lau E; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Yates MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, University of California, San Francisco, CA, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahendra M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma X; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Logothetis C; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kulstad Z; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Feng N; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Federico L; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arur S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moran AE; Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heffernan TP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TPHeffernan@mdanderson.org., Marszalek JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
Publikováno v:
Nature [Nature] 2022 Jun; Vol. 606 (7915), pp. 797-803. Date of Electronic Publication: 2022 Jun 15.
Autor:
Karasarides M; Worldwide Medical Oncology, Bristol Myers Squibb, Princeton, New Jersey., Cogdill AP; Immunai, New York, New York.; Department of Immunology, The University of Texas MD Anderson, Houston, Texas., Robbins PB; Instil Bio, Dallas, Texas., Bowden M; Translational Medicine, Bristol Myers Squibb, Cambridge, Massachusetts., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson, Houston, Texas., Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, California., Cesano A; ESSA Pharma Inc., South San Francisco, California., Hammer C; Department of Cancer Immunology, Genentech, South San Francisco, California.; Department of Human Genetics, Genentech, South San Francisco, California., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Horak CE; Global Drug Development, Bristol Myers Squibb, Lawrenceville, New Jersey., McGee HM; Department of Radiation Oncology, City of Hope National Medical Center and Department of Immuno-Oncology, Beckmann Research Institute, City of Hope, Duarte, California., Monette A; Lady Davis Institute for Medical Research, Montréal, Québec, Canada., Rudqvist NP; University of Texas MD Anderson Cancer Center, Houston, Texas., Spencer CN; Department of Informatics, Parker Institute for Cancer Immunotherapy, San Francisco, California.; University of California San Francisco, San Francisco, California., Sweis RF; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.; Committee on Immunology, University of Chicago, Chicago, Illinois.; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois., Vincent BG; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Wennerberg E; The Institute of Cancer Research, London, UK., Yuan J; Translational Oncology, Early Oncology Development Department, Merck Research Laboratories, Rahway, New Jersey., Zappasodi R; Weill Cornell Medicine, New York, New York.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York., Lucey VMH; Worldwide Medical Oncology, Bristol Myers Squibb, Princeton, New Jersey., Wells DK; Immunai, New York, New York.; Parker Institute for Cancer Immunotherapy, San Francisco, California., LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2022 Apr 01; Vol. 10 (4), pp. 372-383.
Autor:
Spencer CN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., McCulloch JA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Vetizou M; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wong MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rodgers T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Badger JH; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Helmink BA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Medicine, Monash University, Melbourne, VIC 3004, Australia., Rodrigues RR; Frederick National Laboratory for Cancer Research, and Microbiome and Genetics Core, Laboratory of Integrative Cancer Immunology, CCR, NCI, NIH, Bethesda, MD 20852, USA., Morgun A; Department of Pharmaceutical Science, Oregon State University, Corvallis, OR 97331, USA., Kim YS; Nutritional Science Research Group, Division of Cancer Prevention, NCI, NIH, Rockville, MD 20850, USA., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hoffman KL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Zheng J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhou Y; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Medik YB; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kahn LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA., Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gaudreau PO; Canadian Cancer Trials Group and Department of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada., Harris AL; Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jamal MA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Baruch EN; Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA., Perez-Guijarro E; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA., Day CP; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA., Merlino G; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA., Pazdrak B; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lochmann BS; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Szczepaniak-Sloane RA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Anderson J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zobniw CM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Posada E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sirmans E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Simon J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Clise-Dwyer K; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Schneider S; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chapman T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Anang NAS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Duncan S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Toker J; Department of Neurosurgery, Harvard University, Cambridge, MA 02138, USA.; Department of Oncology, University of Cambridge, Cambridge CB2 1TN, UK., Malke JC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Woodman SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jensen V; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel., Straussman R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nezi L; Dipartimento di Oncologia Sperimentale, Instituto Europeo di Oncologia, Milan, P.I. 08691440153, Italy., Petrosino JF; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lazar AJ; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hu J; Department of Biostatistics, Columbia University, New York, NY 10032, USA., Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Stem Cell Transplant, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tetzlaff MT; Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, CA 94115, USA., Yan Y; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA., Garrett WS; Department of Molecular Metabolism, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA., Huttenhower C; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cohen L; Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Daniel CR; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2021 Dec 24; Vol. 374 (6575), pp. 1632-1640. Date of Electronic Publication: 2021 Dec 23.
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.
Autor:
Lam KC; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Araya RE; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Huang A; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Leidos Biomedical Research, Bethesda, MD 20892, USA., Chen Q; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Kelly Government Solutions, Bethesda, MD 20892, USA., Di Modica M; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Rodrigues RR; Leidos Biomedical Research, Bethesda, MD 20892, USA; Microbiome and Genetics Core, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Lopès A; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Johnson SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Schwarz B; Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA., Bohrnsen E; Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA., Cogdill AP; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bosio CM; Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lee MP; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Goldszmid RS; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: rgoldszmid@mail.nih.gov.
Publikováno v:
Cell [Cell] 2021 Oct 14; Vol. 184 (21), pp. 5338-5356.e21. Date of Electronic Publication: 2021 Oct 07.
Autor:
Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.; Deparment of Medicine, Monash University, Melbourne, Victoria, Australia., Duong CPM; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iebba V; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France., Chen WS; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Dermatology, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Derosa L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cogdill AP; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wong MC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ferrere G; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Fluckiger A; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Roberti MP; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Opolon P; Gustave Roussy Cancer Campus (GRCC), Villejuif, France., Alou MT; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Yonekura S; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Roh W; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Spencer CN; Department of Informatics, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Curbelo IF; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vence L; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reuben A; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lastrapes M; MD Anderson Cancer Center University of Texas Health Graduate School of Biomedical Sciences (GSBS), Houston, TX, USA., Baruch EN; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cooper ZA; AstraZeneca, Gaithersburg, MD, USA., Prieto PA; Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA., Wani K; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hudgens CW; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Callahan MK; Department of Informatics, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Adamow M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Division of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Division of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ariyan CE; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gaudreau PO; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nezi L; Istituto Europeo di Oncologia, Milan, Italy., Raoult D; Aix-Marseille Université, MEPHI, IRD, IHU Méditerranée Infection, Marseille, France., Mihalcioiu C; Department of Medicine, Faculty of Medicine and Health Sciences, McGill University Health Centre, Montreal, Quebec, Canada., Elkrief A; Cedars Cancer Center, McGill University Health Centre, Montreal, Quebec, Canada., Pezo RC; Division of Medical Oncology, University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Simon JM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu WJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Watowich S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petrosino J; Department of Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Routy B; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France., Zitvogel L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France. laurence.zitvogel@gustaveroussy.fr.; Institut National de la Santé Et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France. laurence.zitvogel@gustaveroussy.fr.; Université Paris-Saclay, Faculté de Médecine Kremlin-Bicêtre, Le Kremlin-Bicêtre, France. laurence.zitvogel@gustaveroussy.fr., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
Publikováno v:
Nature medicine [Nat Med] 2021 Aug; Vol. 27 (8), pp. 1432-1441. Date of Electronic Publication: 2021 Jul 08.
Autor:
Nejman D; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Livyatan I; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Fuks G; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel., Gavert N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Zwang Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Geller LT; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Rotter-Maskowitz A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Weiser R; Division of Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Mallel G; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Gigi E; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Meltser A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Douglas GM; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada., Kamer I; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dadosh T; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel., Levin-Zaidman S; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel., Avnet S; Orthopaedic Pathophysiology and Regenerative Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Atlan T; Department of Bioinformatics, Jerusalem College of Technology, Jerusalem, Israel., Cooper ZA; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cogdill AP; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ologun G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bussi Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Weinberger A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Lotan-Pompan M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Golani O; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Perry G; Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel., Rokah M; Department of Thoracic Surgery, Sheba Medical Center, Ramat Gan, Israel., Bahar-Shany K; Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel., Rozeman EA; Department of Medical Oncology and Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Blank CU; Department of Medical Oncology and Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Ronai A; Pediatric Gastroenterology Institute, Rambam Medical Center, Haifa, Israel., Shaoul R; Pediatric Gastroenterology Institute, Rambam Medical Center, Haifa, Israel., Amit A; Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Department of Obstetrics and Gynecology, Rambam Health Care Campus, Haifa, Israel., Dorfman T; Division of General Surgery, Rambam Health Care Campus, Haifa, Israel.; Ambulatory and Breast Surgery Service, Rambam Health Care Campus, Haifa, Israel., Kremer R; Department of Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel., Cohen ZR; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Department of Neurosurgery, Sheba Medical Center, Ramat Gan, Israel., Harnof S; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Department of Neurosurgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel., Siegal T; Neuro-Oncology Unit, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel., Yehuda-Shnaidman E; Institute of Pathology, Megalab, Maccabi Healthcare Services, Rehovot, Israel., Gal-Yam EN; Breast Oncology Institute, Sheba Medical Center, Ramat Gan, Israel., Shapira H; Institute of Pathology, Megalab, Maccabi Healthcare Services, Rehovot, Israel., Baldini N; Orthopaedic Pathophysiology and Regenerative Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy., Langille MGI; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Department of Pharmacology, Dalhousie University, Halifax, NS, Canada., Ben-Nun A; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Department of Thoracic Surgery, Sheba Medical Center, Ramat Gan, Israel., Kaufman B; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel., Nissan A; Department of Surgical Oncology (Surgery C), Sheba Medical Center, Ramat Gan, Israel., Golan T; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel., Dadiani M; Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel., Levanon K; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel., Bar J; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel., Yust-Katz S; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Neuro-Oncology Unit, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel., Barshack I; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Department of Pathology, Sheba Medical Center, Ramat Gan, Israel., Peeper DS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Raz DJ; Division of Thoracic Surgery, City of Hope Medical Center, Duarte, CA, USA., Segal E; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sandbank J; Institute of Pathology, Megalab, Maccabi Healthcare Services, Rehovot, Israel., Shental N; Department of Mathematics and Computer Science, The Open University of Israel, Ra'anana, Israel., Straussman R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. ravidst@weizmann.ac.il.
Publikováno v:
Science (New York, N.Y.) [Science] 2020 May 29; Vol. 368 (6494), pp. 973-980.
Autor:
Helmink BA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bhelmink@mdanderson.org., Reddy SM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao J; Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Basar R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thakur R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yizhak K; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sade-Feldman M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Broad Institute of the Massachusetts Institute of Technology, Boston, MA, USA., Blando J; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xi Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao H; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu W; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., LeBleu VS; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kugeratski FG; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arora R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woodman S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaudreau PO; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reuben A; Department of Thoracic / Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zapassodi R; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hudgens CW; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ledesma DA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ong S; Nanostring Technologies, Seattle, WA, USA., Bailey M; Nanostring Technologies, Seattle, WA, USA., Warren S; Nanostring Technologies, Seattle, WA, USA., Rao D; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Krijgsman O; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rozeman EA; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Peeper D; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blank CU; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schumacher TN; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Butterfield LH; Departments of Medicine, Surgery, Immunology and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, USA., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kalluri R; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Allison J; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petitprez F; INSERM, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, Centre de Recherche des Cordeliers, Paris, France.; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France., Fridman WH; INSERM, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, Centre de Recherche des Cordeliers, Paris, France., Sautès-Fridman C; INSERM, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, Centre de Recherche des Cordeliers, Paris, France., Hacohen N; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Broad Institute of the Massachusetts Institute of Technology, Boston, MA, USA., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
Publikováno v:
Nature [Nature] 2020 Jan; Vol. 577 (7791), pp. 549-555. Date of Electronic Publication: 2020 Jan 15.
Autor:
Wei SC; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Anang NAS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Sharma R; Computational and Systems Biology Program, Sloan Kettering Institute, New York, NY 10065.; Department of Applied Physics and Applied Mathematics, Columbia University, New York, NY 10027., Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Reuben A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Levine JH; Computational and Systems Biology Program, Sloan Kettering Institute, New York, NY 10065., Cogdill AP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Mancuso JJ; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Wargo JA; Department of Applied Physics and Applied Mathematics, Columbia University, New York, NY 10027.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, New York, NY 10065.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; jallison@mdanderson.org.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Nov 05; Vol. 116 (45), pp. 22699-22709. Date of Electronic Publication: 2019 Oct 21.